Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

1 results about "Protoporphyrin" patented technology

Protoporphyrins are tetrapyrroles containing the following side chains: methyl propionic acid vinyl Protoporphyrin IX is a biochemically widely used carrier molecule for divalent cations. Together with iron the body of the heme- group of hemoglobin, myoglobin and many other heme-containing enzymes like cytochrome c and catalase are formed. Complexed with magnesium-ions the main part of the Chlorophylls are formed. Complexed with zinc-ions it forms Zinc protoporphyrin. The number indicates the position of different side chains, but historically, as the nomenclature has grown, it has done so systematically only in parts. Protoporphyrin IX as a direct precursor of heme is accumulated by patients of erythropoietic protoporphyria, which is one of the genetic disorders of the biosynthesis of the heme -pathway. It causes a severe photosensivity against visible light. The sensitivity of protoporphyrin IX against light is also used as a therapy against different forms of cancer. Protoporphyrins are deposited in the shells of the eggs of some birds as a brown or red pigment, either as a ground colour or as spotting.

A type of Pt 2+ - Carbon dot@protoporphyrin sonodynamic drug delivery system, its preparation method, and applications

This invention belongs to the field of biomedical technology, specifically relating to a Pt 2+ - Carbon dot@protoporphyrin sonodynamic drug delivery system, its preparation method and application, by loading Pt onto the surface of carbon dots 2+ Modification layer, to obtain Pt 2+ After carbon dots are formed, protoporphyrin is loaded onto them to obtain a carbon dot core with Pt loaded on the carbon dot surface. 2+ Modification layer, in Pt 2+ A sonodynamic drug delivery system with a protoporphyrin-modified layer loaded on the outside of the modified layer can be used in anti-tumor drugs to screen liver cancer cells and normal cells. It has good biocompatibility and significant in vivo sonodynamic anti-tumor effects. It can promote the generation of reactive oxygen species, target and remain in the subcutaneous tumor site in vivo for a long time, increase the mortality rate of cancer cells, and inhibit tumor growth. In a 3D constructed in vitro hepatocellular tumor microenvironment model, this drug delivery system still has superior sonodynamic therapeutic effects.
Owner:SHANXI SIX DIMENSIONAL ARTIFICIAL INTELLIGENCE BIOMEDICAL RES INST